Publications by authors named "R Baum"

Claim this Profile
P
Prognostic implications of [¹⁸F]FDG PET and metabolic changes in patients with advanced metastatic neuroendocrine tumors undergoing rechallenge PRRT: final results from a multicenter 10-year survival WARMTH study.
Giulia Santo, Margarida Rodrigues, Diana Paez, Olga Morozova, Levent Kabasakal, Richard P Baum

Theranostics· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-arterial peptide receptor radionuclide therapy (IA-PRRT) in patients with SSTR-expressing neuroendocrine neoplasms: short- and long-term safety and efficacy for up to 13 years.
Jingjing Zhang, Birger Mensel, Richard P Baum

Theranostics· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status of FAP therapy in solid tumors.
Sophie C Siegmund, Emil Novruzov, Eduards Mamlins, Yuriko Mori, Sven Otto, Richard P Baum

Semin Nucl Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review and meta-analysis of the efficacy and safety of [Lu]Lu-edotreotide ([Lu]Lu-DOTATOC) for the treatment of neuroendocrine tumors.
Richard P Baum, Julia G Fricke, Tristan Ruhwedel, Holger Amthauer, Erika Patricia Azorin-Vega

J Neuroendocrinol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First Autopsy-confirmed Complete Remission of Metastatic Neuroendocrine Neoplasm of Tailgut Cyst After a Single Cycle of Alpha-Peptide Receptor Radionuclide Therapy With [225Ac]Ac-DOTA-LM3.
Elisabetta Perrone, Shagufta Shaheen, Pamela L Kunz, Heather C Henri, Richard P Baum

Clin Nucl Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis